Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is a complex, chronic, and often disabling neurological disease. Despite the recent incorporation of new treatment approaches early in the disease course, care providers still face difficult decisions as to which therapy will lead to optimal outcomes and whento in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandari, Daniel S., Sternaman, Debora, Chan, Theodore, Prostko, Chris R., Sapir, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437431/
https://www.ncbi.nlm.nih.gov/pubmed/23206263
http://dx.doi.org/10.18553/jmcp.2012.18.S9-B.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437431/
https://www.ncbi.nlm.nih.gov/pubmed/23206263
http://dx.doi.org/10.18553/jmcp.2012.18.S9-B.1

Ejemplares similares